Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Orvosi Hetilap|July 27, 2022
GLP1 receptor agonists in the therapy of type 2 diabetesGábor Winkler
Orvosi Hetilap|May 29, 2016
[Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug]Gábor Winkler
Orvosi Hetilap|March 27, 2007
[Incretin enhancers, incretin mimetics: from therapeutic concept to clinical application]Gábor Winkler
Orvosi Hetilap|March 23, 2015
[Sulfonylureas in today's blood glucose lowering therapy. New data on advantages and potential barriers of an "old" antidiabetic group]Gábor Winkler
Orvosi Hetilap|April 1, 2014
[The use of gliclazide in individualized sulfonylurea therapy]Gábor Winkler
Orvosi Hetilap|February 12, 2013
[Pleiotropic effects of incretins and antidiabetic drugs with incretine mechanism]Gábor Winkler
Orvosi Hetilap|January 1, 2013
[Metabolic effects of bariatric surgery]Gábor Winkler
Orvosi Hetilap|August 6, 2014
[Is there any progress in the blood glucose lowering therapy of type 2 diabetes?]Gábor Winkler
Orvosi Hetilap|June 17, 2020
Real and misinterpretation of insulin resistance in the clinical practiceGábor Winkler
Orvosi Hetilap|February 11, 2014
[Timely commencement of insulin in type 2 diabetes: benefits and risks]Gábor Winkler
Pageof 6